Journal of Cataract & Refractive Surgery
Volume 36, Issue 6 , Pages 881-884, June 2010

Prevention of lens capsule opacification with ARC neodymium:YAG laser photolysis after phacoemulsification

From Maximilian Eye Clinic (Wehner), Nuremberg, Germany; A.R.C. Laser GmbH (Walker, Thyzel), Nuremberg, Germany; Eye 1st Vision and Laser (Waring), Atlanta, Georgia, and John A. Moran Eye Center (Mamalis), University of Utah, Salt Lake City, Utah, USA

Received 19 February 2010; received in revised form 18 March 2010; accepted 23 March 2010.

We describe a technique that uses a neodymium:YAG (Nd:YAG) laser photolysis system to prevent lens capsule opacification. The photolysis instrument consists of a 1064 nm Nd:YAG laser transmitted along a fiber-optic cable into a handpiece containing an angulated titanium plate that the laser beam strikes, creating plasma and a shockwave that exits the handpiece through an aperture. Under direct visualization, the shockwave is aimed at the inner surface of the anterior capsule, where it removes LECs and proteoglycan attachment molecules; the shockwave probably extends to the capsule fornix, destroying germinal epithelial cells. We report preliminary results in 12 eyes followed for approximately 2.5 years in which the treated nasal anterior capsule remained clear or with only slight opacity and the untreated temporal capsule developed moderate to severe opacification.

Financial Disclosure

No author has a financial or proprietary interest in any material or method mentioned. Additional disclosures are found in the footnotes.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Additional financial disclosures: Dr. Wehner is an unpaid clinical consultant and Dr. Waring a paid consultant to ARC GmbH. Dr. Mamalis receives laboratory and research financial support from ARC GmbH. Dr. Walker and Mr. Thyzel are employees of ARC GmbH.

PII: S0886-3350(10)00445-1

doi:10.1016/j.jcrs.2010.04.003

Journal of Cataract & Refractive Surgery
Volume 36, Issue 6 , Pages 881-884, June 2010